| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| SG&A Expense | $15.3M | — | +3.8% |
| Net Income | -$54.9M | — | -300.7% |
| EPS (Basic) | -$0.49 | — | -253.1% |
| EPS (Diluted) | -$0.49 | — | -253.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $66.5M | +5.1% | +35.3% |
| Total Assets | $21.45B | +2.1% | +38.4% |
| Total Liabilities | $19.12B | +2.0% | +38.6% |
| Stockholders' Equity | $2.34B | +3.4% | +37.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $111.6M | — | +9.9% |
| Investing Cash Flow | -$839.6M | — | +59.8% |
| Financing Cash Flow | $652.3M | — | -69.0% |